Abstract:Abstract Background Gestational diabetes mellitus (GDM) is usually diagnosed between 24th and 28th gestational week using the 75-g oral glucose tolerance test (OGTT). It is difficult to predict GDM before 24th gestational week because fast plasma glucose (FPG) decreases as the gestational age increases. It is controversial that if FPG ≥5.1 mmol/L before 24th gestational week should be intervened or not. The aim of this study was to evaluate the value of FPG to screen GDM before 24th gestational week in women with different pre-pregnancy body mass index (BMI). Methods This was a multi-region retrospective cohort study in China. Women who had a singleton live birth between June 20, 2013 and November 30, 2014, resided in Beijing, Guangzhou and Chengdu, and received prenatal care in 21 selected hospitals, were included in this study. Pre-pregnancy BMI, FPG before the 24th gestational week, and one-step GDM screening with 75 g-OGTT at the 24th to 28th gestational weeks were extracted from medical charts and analyzed. The pregnant women were classified into four groups based on pre-pregnancy BMI: Group A (underweight, BMI < 18.5 kg/m2), Group B (normal, BMI 18.5–23.9 kg/m2), Group C (overweight, BMI 24.0–27.9 kg/m2) and Group D (obesity, BMI ≥28.0 kg/m2). The trend of FPG before 24th week of gestation was described, and the sensitivity and specificity of using FPG before the 24th gestational week to diagnose GDM among different pre-pregnancy BMI groups were reported. Differences in the means between groups were evaluated using independent sample t-test and analysis of variance. Pearson Chi-square test was used for categorical variables. Results The prevalence of GDM was 20.0% (6806/34,087) in the study population. FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. FPG was higher in women with higher pre-pregnancy BMI. FPG before the 24th gestational week and pre-pregnancy BMI could be used to predict GDM. The incidence of GDM in women with FPG ≥5.10 mmol/L in the 19th to 24th gestational weeks and pre-pregnancy overweight or obesity was significantly higher than that in women with FPG ≥5.10 mmol/L and pre-pregnancy BMI <24.0 kg/m2 (78.5% [62/79] vs. 52.9% [64/121], χ2 = 13.425, P < 0.001). Conclusions FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. Pre-pregnancy overweight or obesity was associated with an increased FPG value before the 24th gestational week. FPG ≥5.10 mmol/L between 19 and 24 gestational weeks should be treated as GDM in women with pre-pregnancy overweight and obesity.

Fasting Plasma Glucose as a Primary Screening Test for the Diagnosis of Gestational Diabetes mellitus

Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus

Employing fasting plasma glucose to safely limit the use of oral glucose tolerance tests in pregnancy: a pooled analysis of four Norwegian studies

Detection of insulin level and its significance in OGTT in pregnant women with gestational diabetes mellitus

Insulin Resistance and Lipid Profile During an Oral Glucose Tolerance Test in Women with and Without Gestational Diabetes Mellitus

Fasting C-peptide in Gestational Diabetes Mellitus

Relationship Between Fasting Plasma Glucose in Early Pregnancy and Gestational Glucose Metabolic Disorders

Fasting Glucose Level on the Oral Glucose Tolerance Test Is Associated with the Need for Pharmacotherapy in Gestational Diabetes Mellitus

Simplifying the screening of gestational diabetes by maternal age plus fasting plasma glucose at first prenatal visit: A prospective cohort study

Value of Fasting Plasma Glucose to Screen Gestational Diabetes Mellitus Before the 24th Gestational Week in Women with Different Pre-Pregnancy Body Mass Index.

Gestational diabetes mellitus – Can we do better with postpartum diabetes screening?

High Fasting Plasma Glucose during Early Pregnancy: A Review about Early Gestational Diabetes Mellitus

Development of a fasting blood glucose-based strategy to diagnose women with gestational diabetes mellitus at increased risk of adverse outcomes in a COVID-19 environment

Association Between Fasting Plasma Glucose in Early Pregnancy and Diagnosis of Gestational Diabetes Mellitus

Screening for gestational diabetes mellitus in Nigerian pregnant women using fifty-gram oral glucose challenge test

Fasting blood glucose as a screening measure for late-onset gestational diabetes in the third trimester

Predictive Value of Early Pregnancy Fasting Blood Glucose for Development of Gestational Diabetes Mellitus

Adapting fasting plasma glucose threshold for GDM diagnosis according to the population distribution - An approach to the Danish paradox

Evaluation of the Value of Fasting Plasma Glucose in the First Prenatal Visit to Diagnose Gestational Diabetes Mellitus in China

Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus

Evaluation of the value of fasting plasma glucose in the first trimester for the prediction of adverse pregnancy outcomes